MassBio Member News - Massachusetts Biotechnology Council

Nanobiotix Strengthens U.S. leadership with appointments of Head of U.S. Clinical Development and Director of Investor Relations October 5, 2016

Asymmetrex Announces a New Adult Tissue Stem Cell Counting Contract Service to Pharmaceutical and Stem Cell Medical Companies at BioPharm America 2016 in Boston Asymmetrex, LLC September 27, 2016

Recently at BioPharm America 2016 in Boston, September 13-15, biotech start-up company Asymmetrex announced its new AlphaSTEM Test contract service for counting adult tissue stem cells. In addition to applications for... Read More

Press release: A new approach for deciphering complex immune responses Qlucore September 27, 2016

Innovation

The response to infection is highly variable from one individual to another. The Milieu Intérieur consortium, coordinated by Prof. Matthew Albert (Immunobiology of dendritic cells Unit, Institut Pasteur / Inserm) and Dr... Read More

Diabetic Lower Extremity Symposium Beth Israel Deaconess Medical Center September 26, 2016

Diabetic foot problems represent one of the major diabetes complications that significantly impair the quality of life of diabetic patients and lead to more than 750,000 new diabetic foot ulcers and 70,000 lower extremity... Read More

CHARLES RIVER LABORATORIES AND THE TRI-INSITUTIONAL THERAPEUTICS DISCOVERY INSTITUTE ANNOUNCE STRATEGIC PARTNERSHIP Charles River Labs September 26, 2016

Charles River Laboratories International, Inc. (NYSE: CRL) today announced that it has entered into a strategic partnership agreement with The Tri-Institutional Therapeutics Discovery Institute (Tri-I TDI), intended to... Read More

Preparing for Successful Pre-Approval Inspections (PAI) EG Life Sciences September 19, 2016

The PAI is a crucial step in bringing a drug to market so it’s critical to assemble the correct team to handle all of the different aspects of these inspections. Without the appropriate strategy a drug can be delayed and... Read More

Together again: Former Synageva execs return with startup Kiniksa Kiniksa Pharmaceuticals September 16, 2016

Last year, Synageva Biopharma Corp. went to Alexion Pharmaceuticals Inc. in one of the year’s biggest buyouts – an $8.4 billion cash and stock deal notable for its whopping 140 percent premium. With the ink barely dry... Read More

Sofregen Medical Raises $6.2 Million in Series A Funding from Polaris Partners and Other Founding Investors September 15, 2016

Sofregen Medical Inc., the company pioneering silk-based medical technologies to address soft tissue defects, today announced a $6.2 million Series A financing from Polaris Partners and other founding investors who previously... Read More

Qlucore Newsletter for September: The Steps for RNA-seq analysis Qlucore September 15, 2016

Alerts,
Innovation

The Steps for RNA-seq analysis Read More

Nanobiotix announces submission for first market approval of lead product NBTXR3 in Europe September 13, 2016

NANOBIOTIX (Euronext: NANO - ISIN: FR0011341205), a late clinical-stage nanomedicine company pioneering novel approaches for the local treatment of cancer, has filed for market approval (CE Marking) in Europe for its lead... Read More